0 XP   0   0   0

AlzeCure Pharma










Financial Health of AlzeCure Pharma




Comparing to competitors in the Drug Manufacturers-Specialty & Generic industry




  Industry Rankings  


AlzeCure Pharma
Buy, Hold or Sell?

Should you buy, hold or sell AlzeCure Pharma?

I guess you are interested in AlzeCure Pharma. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse AlzeCure Pharma

Let's start. I'm going to help you getting a better view of AlzeCure Pharma. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is AlzeCure Pharma even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how AlzeCure Pharma is doing in the market. If the company is worth buying. The latest step is to find out how other investors value AlzeCure Pharma. The closing price on 2022-12-02 was kr4.44 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
AlzeCure Pharma Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of AlzeCure Pharma.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit AlzeCure Pharma earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare AlzeCure Pharma to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of 0.0% means that kr0.00 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of AlzeCure Pharma:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.4%-0.4%
TTM-0.3%-0.3%
YOY-0.2%-0.2%
5Y--0.7%+0.7%
10Y--0.1%+0.1%
1.1.2. Return on Assets

Shows how efficient AlzeCure Pharma is using its assets to generate profit.

  • Above 5% is considered healthy but always compare AlzeCure Pharma to the Drug Manufacturers-Specialty & Generic industry mean.
  • -27.4% Return on Assets means that AlzeCure Pharma generated kr-0.27 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of AlzeCure Pharma:

  • The MRQ is -27.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -33.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-27.4%TTM-33.2%+5.8%
TTM-33.2%YOY-20.4%-12.8%
TTM-33.2%5Y-16.4%-16.7%
5Y-16.4%10Y-16.4%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.4%0.1%-27.5%
TTM-33.2%0.1%-33.3%
YOY-20.4%-0.1%-20.3%
5Y-16.4%-0.2%-16.2%
10Y-16.4%0.1%-16.5%
1.1.3. Return on Equity

Shows how efficient AlzeCure Pharma is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare AlzeCure Pharma to the Drug Manufacturers-Specialty & Generic industry mean.
  • -34.9% Return on Equity means AlzeCure Pharma generated kr-0.35 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of AlzeCure Pharma:

  • The MRQ is -34.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -43.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-34.9%TTM-43.5%+8.7%
TTM-43.5%YOY-23.4%-20.1%
TTM-43.5%5Y-19.5%-24.1%
5Y-19.5%10Y-19.5%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-34.9%0.6%-35.5%
TTM-43.5%0.4%-43.9%
YOY-23.4%0.4%-23.8%
5Y-19.5%-0.3%-19.2%
10Y-19.5%0.1%-19.6%

1.2. Operating Efficiency of AlzeCure Pharma.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient AlzeCure Pharma is operating .

  • Measures how much profit AlzeCure Pharma makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare AlzeCure Pharma to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of AlzeCure Pharma:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.5%-2.5%
TTM-1.6%-1.6%
YOY-2.7%-2.7%
5Y-1.8%-1.8%
10Y-0.8%-0.8%
1.2.2. Operating Ratio

Measures how efficient AlzeCure Pharma is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are kr0.00 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of AlzeCure Pharma:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.473-1.473
TTM-1.456-1.456
YOY-1.398-1.398
5Y-1.374-1.374
10Y-1.191-1.191

1.3. Liquidity of AlzeCure Pharma.

1.3. Liquidity
1.3.1. Current Ratio

Measures if AlzeCure Pharma is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 4.56 means the company has kr4.56 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of AlzeCure Pharma:

  • The MRQ is 4.559. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.442. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.559TTM4.442+0.117
TTM4.442YOY9.586-5.144
TTM4.4425Y19.208-14.766
5Y19.20810Y19.2080.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ4.5591.880+2.679
TTM4.4421.901+2.541
YOY9.5862.112+7.474
5Y19.2082.182+17.026
10Y19.2081.891+17.317
1.3.2. Quick Ratio

Measures if AlzeCure Pharma is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare AlzeCure Pharma to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Quick Ratio of 4.29 means the company can pay off kr4.29 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of AlzeCure Pharma:

  • The MRQ is 4.293. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.308. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.293TTM4.308-0.015
TTM4.308YOY9.443-5.135
TTM4.3085Y18.956-14.648
5Y18.95610Y18.9560.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2930.733+3.560
TTM4.3080.796+3.512
YOY9.4430.808+8.635
5Y18.9560.834+18.122
10Y18.9560.821+18.135

1.4. Solvency of AlzeCure Pharma.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of AlzeCure Pharma assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare AlzeCure Pharma to Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.21 means that AlzeCure Pharma assets are financed with 21.4% credit (debt) and the remaining percentage (100% - 21.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of AlzeCure Pharma:

  • The MRQ is 0.214. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.225. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.214TTM0.225-0.011
TTM0.225YOY0.120+0.105
TTM0.2255Y0.096+0.128
5Y0.09610Y0.0960.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2140.437-0.223
TTM0.2250.424-0.199
YOY0.1200.398-0.278
5Y0.0960.398-0.302
10Y0.0960.401-0.305
1.4.2. Debt to Equity Ratio

Measures if AlzeCure Pharma is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare AlzeCure Pharma to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Equity ratio of 27.2% means that company has kr0.27 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of AlzeCure Pharma:

  • The MRQ is 0.272. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.292. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.272TTM0.292-0.020
TTM0.292YOY0.140+0.153
TTM0.2925Y0.115+0.177
5Y0.11510Y0.1150.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2720.652-0.380
TTM0.2920.675-0.383
YOY0.1400.623-0.483
5Y0.1150.684-0.569
10Y0.1150.697-0.582

2. Market Valuation of AlzeCure Pharma

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings AlzeCure Pharma generates.

  • Above 15 is considered overpriced but always compare AlzeCure Pharma to the Drug Manufacturers-Specialty & Generic industry mean.
  • A PE ratio of -25.14 means the investor is paying kr-25.14 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of AlzeCure Pharma:

  • The EOD is -20.299. Company is losing money. -2
  • The MRQ is -25.145. Company is losing money. -2
  • The TTM is -14.334. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-20.299MRQ-25.145+4.846
MRQ-25.145TTM-14.334-10.811
TTM-14.334YOY-23.243+8.909
TTM-14.3345Y-16.109+1.774
5Y-16.10910Y-16.1090.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-20.299-0.124-20.175
MRQ-25.145-0.437-24.708
TTM-14.334-0.102-14.232
YOY-23.24315.340-38.583
5Y-16.1097.916-24.025
10Y-16.1097.700-23.809
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of AlzeCure Pharma.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of AlzeCure Pharma:

  • The MRQ is -27.044. Very Bad. -2
  • The TTM is 4.534. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ-27.044TTM4.534-31.578
TTM4.534YOY93.957-89.423
TTM4.5345Y18.170-13.636
5Y18.17010Y18.1700.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.0440.012-27.056
TTM4.5340.010+4.524
YOY93.9570.004+93.953
5Y18.1700.010+18.160
10Y18.1700.021+18.149

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of AlzeCure Pharma is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 8.77 means the investor is paying kr8.77 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of AlzeCure Pharma:

  • The EOD is 7.077. Seems overpriced? -1
  • The MRQ is 8.767. Seems overpriced? -1
  • The TTM is 5.840. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD7.077MRQ8.767-1.690
MRQ8.767TTM5.840+2.926
TTM5.840YOY5.339+0.501
TTM5.8405Y2.936+2.904
5Y2.93610Y2.9360.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD7.0771.415+5.662
MRQ8.7671.586+7.181
TTM5.8402.019+3.821
YOY5.3392.230+3.109
5Y2.9361.895+1.041
10Y2.9361.505+1.431
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of AlzeCure Pharma compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.213-0.117-45%-0.359+68%0.031-781%0.031-781%
Book Value Growth--0.8690.879-1%0.880-1%0.895-3%0.895-3%
Book Value Per Share--0.6270.833-25%1.608-61%2.175-71%2.175-71%
Book Value Per Share Growth---0.340-0.252-26%-0.234-31%-0.087-74%-0.087-74%
Current Ratio--4.5594.442+3%9.586-52%19.208-76%19.208-76%
Debt To Asset Ratio--0.2140.225-5%0.120+78%0.096+122%0.096+122%
Debt To Equity Ratio--0.2720.292-7%0.140+95%0.115+136%0.115+136%
Dividend Per Share----0%-0%-0%-0%
Eps---0.219-0.334+53%-0.359+64%-0.283+29%-0.283+29%
Eps Growth--0.9300.260+258%0.099+838%0.030+2970%0.030+2970%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio7.077-24%8.7675.840+50%5.339+64%2.936+199%2.936+199%
Pe Ratio-20.299+19%-25.145-14.334-43%-23.243-8%-16.109-36%-16.109-36%
Peg Ratio---27.0444.534-696%93.957-129%18.170-249%18.170-249%
Price Per Share4.440-24%5.5004.266+29%8.135-32%4.914+12%4.914+12%
Price To Total Gains Ratio-20.797+19%-25.762-9.780-62%-23.243-10%-16.762-35%-16.762-35%
Profit Growth---81.165-87.761+8%-89.339+10%-89.947+11%-89.947+11%
Quick Ratio--4.2934.3080%9.443-55%18.956-77%18.956-77%
Return On Assets---0.274-0.332+21%-0.204-26%-0.164-40%-0.164-40%
Return On Equity---0.349-0.435+25%-0.234-33%-0.195-44%-0.195-44%
Total Gains Per Share---0.213-0.117-45%-0.359+68%0.031-781%0.031-781%
Total Gains Per Share Growth--0.755-0.059+108%0.099+662%-0.793+205%-0.793+205%
Usd Book Value--3087316.0004107901.500-25%7911344.250-61%10704978.200-71%10704978.200-71%
Usd Book Value Change Per Share---0.021-0.011-45%-0.035+68%0.003-781%0.003-781%
Usd Book Value Per Share--0.0610.081-25%0.156-61%0.211-71%0.211-71%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.021-0.032+53%-0.035+64%-0.027+29%-0.027+29%
Usd Price Per Share0.431-24%0.5340.414+29%0.789-32%0.477+12%0.477+12%
Usd Profit---1076409.000-1646817.500+53%-1767388.500+64%-1391722.050+29%-1391722.050+29%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.021-0.011-45%-0.035+68%0.003-781%0.003-781%
 EOD+3 -2MRQTTM+14 -13YOY+13 -145Y+9 -1810Y+9 -18

3.2. Fundamental Score

Let's check the fundamental score of AlzeCure Pharma based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-20.299
Price to Book Ratio (EOD)Between0-17.077
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.293
Current Ratio (MRQ)Greater than14.559
Debt to Asset Ratio (MRQ)Less than10.214
Debt to Equity Ratio (MRQ)Less than10.272
Return on Equity (MRQ)Greater than0.15-0.349
Return on Assets (MRQ)Greater than0.05-0.274
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of AlzeCure Pharma based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.862
Ma 20Greater thanMa 504.032
Ma 50Greater thanMa 1004.492
Ma 100Greater thanMa 2004.043
OpenGreater thanClose4.500
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in SEK. All numbers in thousands.

Summary
Total Assets40,486
Total Liabilities8,658
Total Stockholder Equity31,828
 As reported
Total Liabilities 8,658
Total Stockholder Equity+ 31,828
Total Assets = 40,486

Assets

Total Assets40,486
Total Current Assets39,474
Long-term Assets39,474
Total Current Assets
Cash And Cash Equivalents 37,169
Other Current Assets 2,305
Total Current Assets  (as reported)39,474
Total Current Assets  (calculated)39,474
+/-0
Long-term Assets
Property Plant Equipment 988
Intangible Assets 17
Long-term Assets Other 7
Long-term Assets  (as reported)1,012
Long-term Assets  (calculated)1,012
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities8,658
Long-term Liabilities0
Total Stockholder Equity31,828
Total Current Liabilities
Accounts payable 3,117
Other Current Liabilities 5,541
Total Current Liabilities  (as reported)8,658
Total Current Liabilities  (calculated)8,658
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock1,268
Retained Earnings -292,103
Capital Surplus 322,663
Total Stockholder Equity (as reported)31,828
Total Stockholder Equity (calculated)31,828
+/-0
Other
Capital Stock1,268
Cash and Short Term Investments 37,169
Common Stock Shares Outstanding 50,733
Liabilities and Stockholders Equity 40,486
Net Debt -37,169
Net Invested Capital 31,828
Net Working Capital 30,816



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
> Total Assets 
55,971
0
0
66,969
237,782
225,876
215,418
201,596
186,755
176,406
160,057
138,334
117,827
99,065
82,030
68,299
45,647
75,561
55,303
40,486
40,48655,30375,56145,64768,29982,03099,065117,827138,334160,057176,406186,755201,596215,418225,876237,78266,9690055,971
   > Total Current Assets 
55,705
0
0
66,305
237,161
224,581
214,074
200,051
184,963
174,696
158,185
136,397
115,859
97,221
80,293
66,708
44,201
74,259
54,146
39,474
39,47454,14674,25944,20166,70880,29397,221115,859136,397158,185174,696184,963200,051214,074224,581237,16166,3050055,705
       Cash And Cash Equivalents 
53,952
0
0
65,746
234,549
222,054
210,315
196,842
182,499
172,230
153,325
132,976
112,434
94,163
77,915
62,672
41,741
25,683
51,673
37,169
37,16951,67325,68341,74162,67277,91594,163112,434132,976153,325172,230182,499196,842210,315222,054234,54965,7460053,952
       Net Receivables 
0
0
0
0
0
0
8
8
1,934
1,356
2,824
2,753
2,357
1,589
1,323
1,708
1,539
46,985
1,452
0
01,45246,9851,5391,7081,3231,5892,3572,7532,8241,3561,93488000000
       Other Current Assets 
1,753
0
0
559
2,612
2,527
3,759
3,209
2,464
2,466
4,860
3,421
3,425
3,058
2,378
4,036
2,460
48,576
2,473
2,305
2,3052,47348,5762,4604,0362,3783,0583,4253,4214,8602,4662,4643,2093,7592,5272,612559001,753
   > Long-term Assets 
266
0
0
664
621
1,295
1,344
1,545
1,792
1,710
1,872
1,937
1,968
1,844
1,737
1,591
1,446
1,302
1,157
1,012
1,0121,1571,3021,4461,5911,7371,8441,9681,9371,8721,7101,7921,5451,3441,29562166400266
       Property Plant Equipment 
242
0
0
640
597
1,271
1,320
1,521
1,768
1,686
1,848
1,913
1,944
1,820
1,713
1,567
1,422
1,278
1,133
988
9881,1331,2781,4221,5671,7131,8201,9441,9131,8481,6861,7681,5211,3201,27159764000242
       Intangible Assets 
17
0
0
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17171717171717171717171717171717170017
       Long-term Assets Other 
7
0
0
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
77777777777777777007
> Total Liabilities 
4,146
0
0
2,543
4,613
4,674
4,394
3,954
4,748
8,183
10,127
9,859
7,072
11,272
9,930
12,706
12,673
13,890
12,378
8,658
8,65812,37813,89012,67312,7069,93011,2727,0729,85910,1278,1834,7483,9544,3944,6744,6132,543004,146
   > Total Current Liabilities 
4,146
0
0
2,543
4,613
4,674
4,394
3,954
4,748
8,183
10,127
9,859
7,072
11,272
9,930
12,706
12,673
13,890
12,378
8,658
8,65812,37813,89012,67312,7069,93011,2727,0729,85910,1278,1834,7483,9544,3944,6744,6132,543004,146
       Accounts payable 
1,332
0
0
1,672
3,646
3,802
3,785
2,707
2,997
6,391
7,636
7,812
3,966
7,232
5,865
7,722
5,971
4,030
4,463
3,117
3,1174,4634,0305,9717,7225,8657,2323,9667,8127,6366,3912,9972,7073,7853,8023,6461,672001,332
       Other Current Liabilities 
2,814
0
0
871
967
872
609
1,247
1,751
1,792
2,491
2,047
3,106
4,040
4,065
4,984
5,168
9,860
7,915
5,541
5,5417,9159,8605,1684,9844,0654,0403,1062,0472,4911,7921,7511,247609872967871002,814
   > Long-term Liabilities 00000000000000000000
> Total Stockholder Equity
51,825
0
0
64,426
233,169
221,202
211,024
197,642
182,007
168,223
149,930
128,475
110,755
87,793
72,100
55,593
32,974
61,671
42,925
31,828
31,82842,92561,67132,97455,59372,10087,793110,755128,475149,930168,223182,007197,642211,024221,202233,16964,4260051,825
   Common Stock
189
0
0
235
944
944
944
944
944
944
944
944
944
944
944
944
944
944
1,268
1,268
1,2681,26894494494494494494494494494494494494494494423500189
   Retained Earnings -292,103-281,006-259,458-246,812-224,193-207,686-191,993-169,031-151,311-129,856-111,449-97,665-82,030-68,648-58,393-46,807-33,84000-10,822
   Capital Surplus 
0
0
0
0
0
0
0
0
278,728
278,728
278,842
278,842
278,842
278,842
278,842
278,842
278,842
319,882
322,663
322,663
322,663322,663319,882278,842278,842278,842278,842278,842278,842278,842278,728278,72800000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
62,458
0
0
98,031
279,032
278,651
278,728
278,728
278,728
278,728
278,842
278,842
278,842
278,842
278,842
278,842
278,842
320,185
322,663
322,663
322,663322,663320,185278,842278,842278,842278,842278,842278,842278,842278,728278,728278,728278,728278,651279,03298,0310062,458



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-78,143
Operating Income-77,926-78,143
 
Operating Expense (+$)
Research Development66,715
Selling General Administrative11,265
Selling And Marketing Expenses-
Operating Expense78,14377,980
 
Net Interest Income (+$)
Interest Income146
Interest Expense-1
Net Interest Income145145
 
Pretax Income (+$)
Operating Income-77,926
Net Interest Income145
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-77,781-78,071
EBIT - interestExpense = -77,781
-77,781
-77,780
Interest Expense1
Earnings Before Interest and Taxes (ebit)-77,780-77,780
Earnings Before Interest and Taxes (ebitda)-77,204
 
After tax Income (+$)
Income Before Tax-77,781
Tax Provision--
Net Income From Continuing Ops-77,781-77,781
Net Income-77,781
Net Income Applicable To Common Shares-77,781
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses78,143
Total Other Income/Expenses Net145-145
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
ZCL.CC
9 hours ago

I found you a Golden Cross on the daily chart of ZCL.CC.

ZCL.CC Daily Candlestick Chart
XPC.CC
9 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of XPC.CC.

XPC.CC Daily Candlestick Chart
XNC.CC
9 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of XNC.CC.

XNC.CC Daily Candlestick Chart
XMY.CC
9 hours ago

I found you a Three White Soldiers Candle Pattern on the daily chart of XMY.CC.

XMY.CC Daily Candlestick Chart
XFT.CC
9 hours ago

I found you a Rising Three Methods Candle Pattern on the daily chart of XFT.CC.

XFT.CC Daily Candlestick Chart
WING.CC
9 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of WING.CC.

WING.CC Daily Candlestick Chart
vUSDC.CC
9 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of vUSDC.CC.

vUSDC.CC Daily Candlestick Chart
VOLLAR.CC
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VOLLAR.CC.

VOLLAR.CC Daily Candlestick Chart
UUU.CC
9 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of UUU.CC.

UUU.CC Daily Candlestick Chart
UGAS.CC
10 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of UGAS.CC.

UGAS.CC Daily Candlestick Chart
UBQ.CC
10 hours ago

I found you a Death Cross on the daily chart of UBQ.CC.

UBQ.CC Daily Candlestick Chart
TRXBULL.CC
10 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TRXBULL.CC.

TRXBULL.CC Daily Candlestick Chart
TH.CC
10 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TH.CC.

TH.CC Daily Candlestick Chart
THC.CC
10 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of THC.CC.

THC.CC Daily Candlestick Chart
TEL.CC
10 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TEL.CC.

TEL.CC Daily Candlestick Chart
SWG.CC
10 hours ago

I found you a Death Cross on the daily chart of SWG.CC.

SWG.CC Daily Candlestick Chart
SNC.CC
10 hours ago

I found you a Death Cross on the daily chart of SNC.CC.

SNC.CC Daily Candlestick Chart
SHROOM.CC
10 hours ago

I found you a Morning Star Candle Pattern on the daily chart of SHROOM.CC.

SHROOM.CC Daily Candlestick Chart
SATT.CC
10 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SATT.CC.

SATT.CC Daily Candlestick Chart
RYO.CC
10 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of RYO.CC.

RYO.CC Daily Candlestick Chart
REAP.CC
10 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of REAP.CC.

REAP.CC Daily Candlestick Chart
RBN.CC
10 hours ago

I found you a Death Cross on the daily chart of RBN.CC.

RBN.CC Daily Candlestick Chart
RAK.CC
10 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RAK.CC.

RAK.CC Daily Candlestick Chart
PLAY.CC
10 hours ago

I found you a Death Cross on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart